RZLT | Rezolute, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	5.15 - 5.35
52 Week Range	0.7200 - 6.10
Beta	0.31
Implied Volatility	539.80%
IV Rank	52.02%
Day's Volume	196,823
Average Volume	324,540
Shares Outstanding	55,356,900
Market Cap	285,088,035
Sector	Healthcare
Industry	Biotechnology
IPO Date	2013-01-14

Valuation
Profitability
Growth
Health
P/E Ratio	-4.52
Forward P/E Ratio	N/A
EPS	-1.14
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	41
Country	USA
Website	RZLT

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

RZLT's peers: AADI, ABIO, ACXP, ADAG, ADVM, ANTX, ANIX, APRE, ATXS, AURA, AUTL, AVTE, BCAB, BCDA, NTRB, BNOX, CADL, PTIX, CCCC, CDXC, CELC, CING, CSBR, CYCC, DBVT, ELYM, FBIOP, FBRX, FHTX, GHRS, GNFT, GNTA, HCWB, ICCC, IKNA, IMNM, INDP, IVA, JANX, LUMO, LVTX, MNOV, MNPR, MOLN, NAUT, NLSP, NNVC, OPT, ORGS, PHAR, PHVS, PRLD, PRTC, FRLN, ELDN, CLNN, RPHM, LRMR, ACRV, SLGL, SVRA, TPST, TRVI, VINC, XOMA, LSTA, NAMS, KA, MLEC

*Chart delayed

Analyzing fundamentals for RZLT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see RZLT Fundamentals page.

Watching at RZLT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on RZLT Technicals page.